ANI Pharmaceuticals Inc (ANIP)
64.59
-0.89
(-1.36%)
USD |
NASDAQ |
Apr 18, 16:00
64.56
-0.02
(-0.04%)
After-Hours: 20:00
ANI Pharmaceuticals Price: 64.59 for April 18, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 18, 2024 | 65.30 | 65.98 | 64.43 | 64.59 | 157383.0 |
| Apr 17, 2024 | 65.56 | 66.06 | 65.02 | 65.48 | 123206.0 |
| Apr 16, 2024 | 66.10 | 66.58 | 65.52 | 65.56 | 99004.00 |
| Apr 15, 2024 | 66.83 | 67.30 | 65.65 | 66.30 | 111916.0 |
| Apr 12, 2024 | 67.79 | 68.17 | 66.41 | 66.88 | 94984.00 |
| Apr 11, 2024 | 67.42 | 68.12 | 66.64 | 68.11 | 136646.0 |
| Apr 10, 2024 | 66.10 | 67.10 | 65.52 | 66.96 | 171036.0 |
| Apr 09, 2024 | 67.37 | 67.60 | 66.75 | 67.05 | 152771.0 |
| Apr 08, 2024 | 68.39 | 68.39 | 67.15 | 67.59 | 117667.0 |
| Apr 05, 2024 | 68.00 | 68.40 | 67.31 | 67.65 | 203207.0 |
| Apr 04, 2024 | 67.68 | 68.32 | 66.94 | 67.94 | 160079.0 |
| Apr 03, 2024 | 66.59 | 67.35 | 66.47 | 67.24 | 177336.0 |
| Apr 02, 2024 | 67.48 | 67.48 | 66.47 | 66.72 | 173569.0 |
| Apr 01, 2024 | 69.02 | 69.02 | 66.50 | 67.87 | 203944.0 |
| Mar 28, 2024 | 69.69 | 70.05 | 69.00 | 69.13 | 252152.0 |
| Mar 27, 2024 | 69.85 | 70.31 | 69.49 | 69.69 | 110842.0 |
| Mar 26, 2024 | 69.63 | 70.21 | 69.10 | 69.55 | 90403.00 |
| Mar 25, 2024 | 70.81 | 70.81 | 69.00 | 69.60 | 117924.0 |
| Mar 22, 2024 | 69.93 | 70.46 | 69.36 | 69.58 | 145907.0 |
| Mar 21, 2024 | 68.58 | 69.46 | 68.33 | 69.32 | 188258.0 |
| Mar 20, 2024 | 67.58 | 68.93 | 67.58 | 68.16 | 112689.0 |
| Mar 19, 2024 | 67.15 | 68.67 | 67.14 | 67.87 | 212224.0 |
| Mar 18, 2024 | 66.04 | 67.89 | 65.82 | 67.62 | 208964.0 |
| Mar 15, 2024 | 65.89 | 67.34 | 65.50 | 66.00 | 332076.0 |
| Mar 14, 2024 | 65.92 | 66.79 | 65.50 | 66.05 | 107392.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
23.09
Minimum
Jun 16 2022
85.39
Maximum
Jul 30 2019
44.81
Average
39.35
Median
Feb 01 2022
Price Benchmarks
| ADMA Biologics Inc | 6.20 |
| Ligand Pharmaceuticals Inc | 72.52 |
| Dentsply Sirona Inc | 30.44 |
| Allogene Therapeutics Inc | 3.45 |
| Vanda Pharmaceuticals Inc | 4.97 |
Price Related Metrics
| PE Ratio | 78.77 |
| PS Ratio | 2.415 |
| Price to Book Value | 3.144 |
| Price to Free Cash Flow | 11.71 |
| Earnings Yield | 1.27% |
| Market Cap | 1.361B |
| Operating PE Ratio | 23.74 |
| Normalized PE Ratio | 70.53 |